{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:39:34Z","timestamp":1793047174297,"version":"4.5.0"},"reference-count":17,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2026,4,7]]},"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1136\/thorax-2026-225029","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:25:48Z","timestamp":1777051548000},"page":"1043-1045","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Is it time to re-evaluate the levels of evidence in medical research: commentary on inhaled corticosteroids in COPD"],"prefix":"10.1136","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8611-4751","authenticated-orcid":false,"given":"Anne E","family":"Ioannides","sequence":"first","affiliation":[{"name":"School of Public Health, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0149-4869","authenticated-orcid":false,"given":"Jennifer K","family":"Quint","sequence":"additional","affiliation":[{"name":"School of Public Health, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"2026102613101039000_81.11.1043.1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-224636"},{"key":"2026102613101039000_81.11.1043.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713901"},{"key":"2026102613101039000_81.11.1043.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916046"},{"key":"2026102613101039000_81.11.1043.4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202312-2311OC"},{"key":"2026102613101039000_81.11.1043.5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202006-2618OC"},{"key":"2026102613101039000_81.11.1043.6","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1164\/rccm.201911-2207OC","article-title":"Reduction in All-Cause Mortality with Fluticasone Furoate\/Umeclidinium\/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease","volume":"201","author":"Lipson","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026102613101039000_81.11.1043.7","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026102613101039000_81.11.1043.8","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-223282"},{"key":"2026102613101039000_81.11.1043.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407154"},{"key":"2026102613101039000_81.11.1043.10","article-title":"Addendum on estimands and sensitivity analysis in clinical trials","volume":"9","author":"Guideline","year":"2017","journal-title":"Clin Trials"},{"key":"2026102613101039000_81.11.1043.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30069-1"},{"key":"2026102613101039000_81.11.1043.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063070"},{"key":"2026102613101039000_81.11.1043.13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.15326\/jcopdf.2022.0386","article-title":"Inhaled Corticosteroids and Risk of Cardiovascular Disease in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Regression","volume":"10","author":"Gadhvi","year":"2023","journal-title":"J COPD F"},{"key":"2026102613101039000_81.11.1043.14","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2024-222113"},{"key":"2026102613101039000_81.11.1043.15","unstructured":"Global Initiative for Chronic Obstructive Lung Disease . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2026 report). Available: https:\/\/goldcopd.org\/2026-gold-report-and-pocket-guide\/ [Accessed 30 Mar 2026]."},{"key":"2026102613101039000_81.11.1043.16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.21383"},{"key":"2026102613101039000_81.11.1043.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2025-084909","article-title":"Starting right: aligning eligibility and treatment assignment at time zero when emulating a target trial","volume":"392","author":"Fu","year":"2026","journal-title":"BMJ"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2026-225029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:10:21Z","timestamp":1793045421000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2026-225029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1136\/thorax-2026-225029"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2026-225029","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]}}}